TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank67
3Y CAGR+62.1%
5Y CAGR+129.7%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+62.1%/yr
Annual compound
5Y CAGR
+129.7%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
63.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$6.78M-43.8%
2024$12.06M+50.8%
2023$8.00M+402.8%
2022$1.59M+9843.8%
2021$16000.00-84.9%
2020$106000.00-80.8%
2019$552000.00-